Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: AIDS. 2020 Apr 1;34(5):699–706. doi: 10.1097/QAD.0000000000002456

Table 2.

Summary of kidney function measures before and six months after PrEP initiation

Measure Baseline (95% CI) Follow-up (95% CI) Relative % Change (95% CI)
Serum creatinine (mg/dL) 0.88 (0.86, 0.91) 0.92 (0.89, 0.95) 4.6 (2.5, 6.7)
Serum cystatin C (mg/L) 0.78 (0.74, 0.83) 0.82 (0.78, 0.87) 5.5 (−0.4, 11.8)
eGFRcr (ml/min/1.73m2) 108.3 (104.7, 112.0) 104.0 (100.2, 107.9) −4.0 (−5.7, −2.4)
eGFRcys (ml/min/1.73m2) 107.0 (101.5, 112.9) 103.5 (98.4, 108.8) −3.3 (−8.3, 1.9)
eGFRcr-cys (ml/min/1.73m2) 111.1 (106.5, 115.9) 106.5 (102.1, 111.1) −4.1 (−7.5, −0.7)

eGFRcr, estimated glomerular filtration rate by creatinine; eGFRcr-cys, estimated glomerular filtration rate by creatinine and cystatin C; eGFRcys, estimated glomerular filtration rate by cystatin C.

Data presented as geometric mean (95% CI).